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ABSTRACT 29 
Adaptation to exercise training is a complex trait that may be influenced by genetic variants. We identified 36 30 
single nucleotide polymorphisms (SNPs) that had been previously associated with endurance or strength 31 
performance, exercise-related phenotypes or exercise intolerant disorders. A MassARRAY multiplex genotyping 32 
assay was designed to identify associations with these SNPs against collected endurance fitness phenotype 33 
parameters obtained from 2 exercise cohorts (Gene SMART study; n=58 and Hawaiian Ironman Triathlon 2008; 34 
n=115). These parameters included peak power output (PP), a time trial (TT), lactate threshold (LT), maximal 35 
oxygen uptake (VO2 max) in recreationally active individuals and a triathlon time to completion (Hawaiian 36 
Ironman Triathlon cohort only). A nominal significance threshold of α<0.05 was used to identify 17 variants (11 37 
in the Gene SMART population and 6 in the Hawaiian Ironman Triathlon cohort) which were significantly 38 
associated with performance gains in highly trained individuals. The variant rs1474347 located in Interleukin 6 39 
(IL6) was the only variant with a false discovery rate < 0.05 and was found to be associated with gains in VO2 40 
max (additional 4.016 mL/(kg·min) for each G allele inherited) after training in the Gene SMART cohort. In 41 
summary, this study found further evidence to suggest that genetic variance can influence training response in a 42 
moderately trained cohort and provides an example of the potential application of genomic research in the 43 
assessment of exercise trait response.  44 
  45 
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INTRODUCTION 48 
Currently, robust identification of genetic variants associated with exercise phenotypes is limited by a lack of 49 
reproducible results. Family and twin studies have estimated high heritability for various exercise performance 50 
metrics (e.g. muscle mass: 40%, anaerobic power: 70-80%, aerobic exercise: 50%) [1]. However, a wide variety 51 
of environmental (e.g. diet, sleep), psychological and epigenetic factors may also influence exercise responses 52 
[2]. In addition, within-subject variability (i.e. the variable response of a given individual to the same exercise 53 
training) considerably limits the identification of genetic variants with potentially small effects on exercise 54 
response [3].  55 
To date, only two genetic signatures have consistently shown an association with exercise responses; the Alpha-56 
actinin-3 stop gain variant (ACTN3) p.Arg577Ter and the Angiotensin converting enzyme (ACE) 57 
Insertion/Deletion (I /D) in intron 16 [4, 5]. Genome Wide Association Studies (GWAS) have helped discern 58 
genomic loci associated with training response, however these usually contain a low number of participants, 59 
and/or evidence of association with exercise psychology related phenotypes [6]. Studies in metabolic and 60 
cardiovascular disorders such as diabetes or arterial hypertension have further complicated participant ability to 61 
perform exercise training at duration and intensity and as such participants can be classified as having exercise 62 
intolerant disorders [7]. As exercise training yields a host of health benefits, understanding which genetic and 63 
molecular processes contribute to these responses might be helpful to the development of personalised exercise 64 
therapeutics (e.g. exercise dosing to minimise risk of adverse response within exercise intolerant disorders) [8].  65 
In this study, we investigated candidate genes previously implicated in exercise response in cohorts of varying 66 
fitness levels. We used a highly trained cohort (triathlon) and a moderately trained, longitudinal cohort of High-67 
Intensity Interval endurance Training (HIIT) exercise training. We hypothesised that many, if not all, of the 68 
candidate SNPs would be found to be associated with triathlon performance and response to 4 weeks of endurance 69 
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MATERIALS AND METHODS 73 
The Gene SMART cohort  74 
The Gene SMART (Skeletal Muscle Adaptive Response to Training) study design has previously been described 75 
[9]. The study is ongoing with currently > 100 moderately-trained participants who were sampled for blood and 76 
skeletal muscle (vastus lateralis) at several time points: before, immediately after and 3 hours after a single bout 77 
of high-intensity endurance exercise (HIIE), and after 4 weeks of High-Intensity Interval Training (HIIT) [9]. 78 
Exercise-related phenotypic measurements were collected before and after the completion of the exercise training 79 
intervention (e.g. Lactate Threshold (LT, in Watts), Peak Power output (PP, in Watts), maximal oxygen uptake 80 
(VO2max, in mL/min/kg body weight, from graded exercise tests), and a Time Trial measurement (TT, in min). 81 
All participants gave informed consent and the study was approved by the Victoria University Ethics Committee 82 
(Approval number: HRE13-233). Subsequently, the study was also approved by the Queensland University of 83 
Technology (QUT) Human Research Ethics Committee (Approval number: 1600000342). All procedures 84 
performed in studies involving human participants were in accordance with the ethical standards of the respective 85 
institutions research committees, and with the 1964 Helsinki declaration and its later amendments or comparable 86 
ethical standards. At the time of collection, n = 77 participants had participated in the study, with n = 58 completing 87 
the entire 4-week training program. Genomic DNA was extracted and purified from whole blood using the 88 
QIAamp DNA blood midi kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions for 89 
participants that completed the study. Samples that failed genotypic analysis or had a large amount of missing 90 
phenotypic data, were removed from further analysis, leaving a final sample size of n = 52 (Age = 30.95 ± 8.17 91 
years). In the moderately trained cohort (Gene SMART, n = 58), we focused on the response to an exercise training 92 
program (longitudinal analysis). Specifically, we measured the change in (Δ = post - pre) measurement for each 93 
endurance fitness trait as a representation of response to exercise training.  94 
Highly trained (Ironman) cohort 95 
Ironman triathlons consist of a 3.86 km swim, a 180.25 km bike ride, followed by the completion of a full marathon 96 
(42.2 km). The 2008 Hawaiian Ironman Triathlon population has been previously described as an elite endurance 97 
cohort based on their eligibility and participation in the event [10, 11]. Due to the intensity of this endurance event 98 
only highly trained individuals that completed it were included in this study. To avoid genetic confounding, we 99 
analysed only the triathlon participants who self-identified as male and Caucasian (Age = 43.81 ± 11.39 years). 100 
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This was performed solely on the triathlon group as the Gene SMART population was already homogeneously 101 
male. All procedures performed in studies involving human participants were in accordance with the ethical 102 
standards of the QUT human Research Ethics Committee (approval number: 1300000499), and with the 1964 103 
Helsinki declaration and its later amendments or comparable ethical standards. Saliva samples (OG-250 Oragene 104 
Kit, DNA Genotek Inc.) and questionnaires were collected prior to the event; time to completion measurements 105 
for each event was collected from the publicly available online event webpage. Genomic DNA was extracted as 106 
per manufacturer instructions and described previously [11]. In the highly trained cohort (Ironman, n = 115), we 107 
focused on endurance performance, the result of months or years of training (cross-sectional analysis). 108 
Specifically, we used the time to completion of the running event, the biking event, the swimming event, and the 109 
total event.  110 
 111 
Genotype method and SNP selection 112 
The SNPs investigated in this study (Table I) were included based on conformity of 1 of 3 criteria. The first was 113 
that SNPs chosen had to have been previously associated with elite athletic status, exercise responses with 114 
reasonable replication, or exercise traits at baseline. This resulted in 11 SNPs chosen, though it should be noted 115 
that we were unable to genotype the ACE I/D variant (rs4340) using the MassARRAY and previous work failed 116 
to identify an association with baseline fitness levels in the Gene SMART cohort [4]. The second criteria 117 
encompassed SNPs previously investigated but less consistently associated with performance i.e. studies with 118 
equivalent numbers of negative studies or studies related to exercise psychology. The third criteria included SNPs 119 
associated with exercise intolerant disorders and non-exercise respiratory, muscular, or energy storage phenotypes 120 
such as hypertension (HT), cardiovascular disease (CVD), or Type 2 Diabetes Mellitus (T2DM). The experimental 121 
methodology for sample preparation and genotype analysis was performed using the Agena Biosciences 122 
MassARRAY, a Matrix Assisted Laser Desorption Ionisation Time of Flight (MALDI-TOF) mass spectrometer, 123 
which has been described elsewhere [12, 13]. An internal genotyping control SNP (rs17602729, AMPD1), 124 
previously validated in our endurance cohort, was used to ensure the MassARRAY system correctly identified 125 
genotypes [10]. 126 
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Table I: Details on the 36 SNPs included in the custom MassARRAY genotyping assay.  127 
CHR Gene SNP ID A1 Phenotype(s) 
Number of studies 
with positive 
results 
Number of participants in 
studies with positive 
results 
Number of studies 
with negative 
results 
Number of participants in 
studies with negative 
results 
Ref 
 Category 1: Well replicated or solely exercise associations 











6 HFE rs1799945 G END 2 148 - - [14] 
6 VEGFA rs2010963 C END 1 942 - - [14] 






















19 CKMM rs8111989 G POW 2 233 - - [14] 
21 COL6A1 rs35796750 T END 1 661 - - [14] 











 Category 2: Mixed results 
































4 PGC1α rs8192678 A END 4 849 3 508 [14] 









4 PGC1α rs6821591 T END 1 235 - - [18] 
5 ADRB2 rs1042713 A POW 1 100 - - [14] 
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CHR Gene SNP ID A1 Phenotype 
Number of studies 
with positive 
results 
Number of participants in 
studies with positive 
results 
Number of studies 
with negative 
results 
Number of participants in 
studies with negative 
results 
Ref 
 Category 2 continued: Mixed results 
7 NRF1 rs6949152 G END 1 102 1 75 [19, 20] 
8 ADRB3 rs4994 C END 1 100 1 81 [14] 
14 BDKRB2 rs1799722 T END 1 316 - - [14] 
15 NRF2 rs7181866 G END 2 129 1 89 [14] 
15 NRF2 rs8031031 T END 1 74 1 89 [14] 
 Category 3: Disease Associations and other 
1 ATP1A2§ rs28933400 T HYP - - 1 388 [21] 
1 LEPR rs12405556 T EBH 2 978 - - [15] 
1 DIO1 rs2294512 A THY 1 547 - - [22] 
2 MSTN rs1805086 G POW 13 3,080 - - [10, 23] 
4 UCP1 rs2270565 T T2D 2 981 4 1,382 [24-26] 
6 EDN1 rs5370 T HYP 2 1,004 - - [27, 28] 
6 HLA-A rs1061235 T END 1 32 - - [16] 
7 IL6 rs1474347 A T2D 1 10,775 - - [29, 30] 











12 IGF1 rs121912430 T OBE 1 502 - - [16] 
15 CYP19A1‡ rs2470158 T EBH 1 1,722 - - [15] 
16 Intronic rs238838 C - - - - - [16] 
18 MC4R rs9965495 A T2D 2 6,657 - - [15, 33] 
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 128 
NB: Grey rows represent intergenic variants included from GWAS conducted by Rankinen et al. [16].  129 
Phenotypes are the traits in which the SNP has been previously implicated. Previous studies and numbers of participants are shown and separated according to 130 
positive or negative results. SNPs are separated into three categories based on phenotype and replication (adapted from Ahmetov I.I. et al,.[14]). END: Endurance, 131 
POW: Power/Strength, T2D: Diabetes, HYP: Hypertension, EBH: Exercise behaviour, OBE: Obesity, †: Inbuilt genotyping control, A1: Tested Allele 132 
‡ excluded in Gene SMART population.  133 
§ Excluded from highly trained population.  134 
 135 
CHR Gene RS# A1 Phenotype(s) 








 Category 3: Disease Associations and other 




































MT MTTT rs199474700 G END 1 46 - - [16] 
MT MTND5 rs28359178 A END 1 46 - - [16] 
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Data processing 136 
The output files from the MassARRAY platform were converted to PLINK format and analysed for correct 137 
genotypic identification (calling). For the Gene SMART and Ironman populations respectively, SNPs were 138 
excluded from further analysis if they exceeded the following thresholds: 1) SNPs that had a calling rate < 80% 139 
(>20% missing data) (n = 5, n = 3); 2) SNPs with a minor allele frequency < 2% (n = 1, n = 2); 3) SNPs determined 140 
not in hardy Weinberg equilibrium (n=1, n=1) [12]. Subsequent analysis was performed on n = 29 SNPs for the 141 
Gene SMART population and n = 30 SNPs for the Ironman population.  142 
Statistical analysis 143 
We measured normality metrics (skewness and kurtosis) for each phenotype in both populations using the ggplot2, 144 
tidyverse and moments packages in R, to determine if data transformation was necessary from the raw phenotypic 145 
values. We used PLINK V1.90p to perform quantitative linear association tests (95% CI) with both dominant and 146 
recessive models for each cohort, adjusting for age. An additive model was considered but did not differ from the 147 
results obtained from the dominant model. As this was a candidate gene study, SNPs that had a raw p-value < 148 
0.05 were considered nominally significant while variants that had an adjusted p-value (Benjamini-Hochberg 149 
False Discovery Rate (FDR)) < 0.05 were considered significant. This adjustment method represents a good 150 
balance between type I and type II errors and as such minimises false positive results. To avoid multiple testing 151 
burdens with phenotypic traits, we used a separate hypothesis for each quantitative trait. Effect sizes were 152 
determined using raw beta regression coefficient values interpreted as “how much a specific phenotype increased 153 
for each additional X allele at the SNP of interest”.  154 
 155 
RESULTS 156 
The array genotyping control (AMPD1) was identified to be 100% concordant with the 157 
genotyping results from another method (RFLP) in our previous study with the same 158 
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Table II: Summary of nominally significant variants associated with gains in endurance fitness after exercise training in the Gene SMART cohort. Tests were 161 
performed for both dominant and recessive models for each trait: Wpeak: maximum ergometer intensity at stop (Watts), LT: Lactate Threshold (Watts), VO2max: maximum 162 
oxidative respiration uptake (mL/(kg·min)), TT: time trial completion (seconds). 163 
 164 
CHR = Chromosome, SNP = Single Nucleotide Polymorphism, DOM = Dominant model, REC = Recessive model, MAF = Minor Allele Frequency, FDR = False Discovery 165 
Rate 166 
†P-value adjusted for age 167 
 168 
 169 
Trait CHR SNP Allele 
Gene 
Symbol 
Type of SNP Model MAF P-value† FDR 
Effect size 
(Beta) 
Δ-Wpeak 1 rs17602729 A AMPD1 Stop-gain DOM 0.098 0.009 0.162 13.75 
16 rs238838 A - Intronic DOM 0.11 0.01 0.162 -15.24 
1 rs2294512 C DIO1 Intronic DOM 0.042 0.043 0.393 -16.8 
Δ-LT 14 rs1799722 T BDKRB2 5`UTR variant REC 0.33 0.027 0.24 -17.17 
15 rs8031031 T NRF2 Intronic REC 0.016 0.027 0.24 -37.34 
21 rs35796750 T COL6A1 Intronic REC 0.48 0.035 0.24 11.88 
19 rs7412 T APOE Missense DOM 0.105 0.042 0.64 -11.95 
18 rs9965495 A MC4R Intronic DOM 0.28 0.045 0.64 9.107 
Δ-VO2max 7 rs1474347 C IL6 Intronic REC 0.45 0.00087 0.018 -4.016 
11 rs660339 A UCP2 Missense REC 0.46 0.037 0.38 -2.835 
15 rs8031031 T NRF2 Intronic DOM 0.04 0.04 0.87 4.741 
Δ-TT 6 rs1799945 G HFE Missense DOM 0.21 0.019 0.58 101 
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Table III: All nominally significant variants associated with different triathlon event finishing times in the highly trained endurance cohort. SNPs were determined 170 
nominally significant under an arbitrary α<0.05 threshold. FDR adjusted results are shown for all nominal variants. All traits are shown in hours.  171 
CHR = Chromosome, SNP = Single Nucleotide Polymorphism, DOM = Dominant model, REC = Recessive model, MAF = Minor Allele Frequency, FDR = False Discovery 172 
Rate 173 
†P-value adjusted for age 174 
Trait 
CHR SNP Allele Gene Symbol Effect Model MAF P-value† FDR  
Effect size 
(Beta) 
Swim time 7 rs6949152 G NRF1 Intronic REC 0.14 0.019 0.47 0.2459 
19 rs8111989 G CKMM Downstream variant DOM 0.34 0.019 0.31 -0.0903 
6 rs1061235 T HLA-A Non-coding transcript DOM 0.061 0.02 0.31 0.1392 
Cycle time 1 rs9633417 A SGIP1 Intronic DOM 0.1 0.036 0.89 0.3238 
4 rs8192678 A PGC1α Missense REC 0.36 0.038 0.40 0.2965 
4 rs6821591 A PGC1α Non-coding transcript REC 0.45 0.041 0.40 -0.2977 
Run time 1 rs9633417 A SGIP1 Intronic DOM 0.1 0.019 0.61 0.424 
Total-time 1 rs9633417 A SGIP1 Intronic DOM 0.1 0.012 0.37 0.846 
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Six variants in five distinct genes were nominally associated with time-to-completion of Ironman events: Nuclear 175 
Respiratory Factor 1 (NRF1: rs6949152), Myostatin (MSTN: rs1805086), Major Histocompatibility complex 176 
class 1A (HLA-A: rs1061235), Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 177 
(PPARGC1α: rs6821591, rs6821591), and SH3 Domain GRB2 Like Endophilin Interacting Protein (SGIP1: 178 
rs9633417). The results of our association testing did not change significantly when age was used as a covariate.  179 
In the Gene SMART cohort, eleven variants in nine distinct genes were shown to be nominally associated with 180 
gains in endurance fitness following exercise training (Table II): Adenosine Monophosphate Deaminase 1 181 
(AMPD1: rs17602729), Iodothyronine Deiodinase 1 (DIO1: rs2294512), Bradykinin receptor B2 (BDKRB2: 182 
rs1799722), Nuclear Respiratory Factor 2 (NRF2: rs7181866, rs8031031), (COL6A1, rs39796750), 183 
Apolipoprotein E (APOE: rs7412), Interleukin 6 (IL6: rs1474347), Mitochondrial uncoupling protein 2 (UCP2: 184 
rs660339), and Homeostatic Iron Regulator (HFE: rs1799945).  185 
Interestingly, no variants were identified to be significantly associated with both time-to-completion in the 186 
Ironman cohort and the response to endurance exercise training in the Gene SMART cohort. Only rs1474347 in 187 
IL6 passed correction for multiple testing using the BH-FDR method (FDR: 0.018). The C allele at rs1474347 188 
was associated with VO2max response within the Gene SMART study with an effect size of -4.016mL/(kg·min).  189 
 190 
DISCUSSION 191 
In the present study, we have successfully replicated previously associated exercise-related SNPs using the 192 
combined data from highly trained and moderately trained cohorts. Our main findings identified the rs1474347 in 193 
the IL6 gene to be significantly associated with gains in VO2 max in the Gene SMART cohort after multiple-194 
testing statistical corrections. In addition, 17 genetic variants were found to be associated with either elite 195 
performance or responses to exercise, however, none of these variants were common between these cohorts.  196 
Different genetic signatures likely confer different responses to exercise training via specific molecular pathways. 197 
Therefore, variants that influence pathways responsible for adaptation to moderate training may in part differ to 198 
those that confer response to high intensity endurance training. Additionally, moderately trained cohorts typically 199 
contain individuals with large variability in environmental factors such as diet, sleep and habitual physical activity 200 
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patterns, while the inter-individual variability in these measures is smaller in highly-trained cohorts and therefore 201 
less likely to confound results [47]. 202 
Association between genetic variants and exercise responses in the Gene SMART cohort 203 
Located in an intron of the IL6 gene, the rs1474347 variant has been previously associated with T2D traits in a 204 
large-scale study (n = 10,775). The IL6 protein is a pro-inflammatory cytokine with myokinetic (i.e. excreted from 205 
skeletal muscle) functions and is responsible for triggering and maintaining immune processes following post-206 
exercise muscle damage [48]. We found that the C allele at this locus negatively affected the exercise response to 207 
the VO2max phenotype (β = -4.016mL/kg·min) and therefore a homozygous C/C genotype would result in a 208 
VO2max loss of -8.032 mL/kg·min.. The rs1800795 coding variant within the IL6 gene has shown mixed evidence 209 
of exercise associations i.e. variant C = athleticism, G = power [14, 49]. Interestingly, further analysis identified 210 
the rs1474347 C allele to be in strong linkage disequilibrium (LD) with the C allele of rs1800795 (R2 = 0.96). As 211 
such, it is feasible that the LD identified between these variants has contributed to the mixed evidence reported 212 
for association studies implicating the latter variant (rs1800795) in IL6 for exercise traits. We propose that the 213 
rs1474347 variant may reduce the expression of IL6 during acute muscle damage and therefore cause a reduced 214 
local immune response leading to loss of skeletal muscle remodelling and repair. In addition this variant is also 215 
located 2kb upstream of an uncharacterised long non-coding RNA (lncRNA; LOC541472) and therefore, variants 216 
in this region may affect the IL-6 pro-inflammatory pathway or post-translational epigenetic and regulatory 217 
processes. 218 
Association between genetic variants and Ironman performance 219 
The run time (42.2 km marathon), and bike time (180.25 km ride) events in the triathlon are largely leg-based 220 
exercise activities, and therefore we expected a significant overlap of variants associated with these traits. In 221 
contrast, the triathlon swimming event utilises whole body muscle groups, therefore SNPs seen in this test were 222 
anticipated to only be associated with this particular trait. Our findings supported this as the variants associated 223 
with the swim time event were not seen in either of the other isolated finishing times, or indeed the total time to 224 
completion trait. This is also supported by the current literature where elite runners and swimmers are not analysed 225 
collectively [50]. We also note that the two variants nominally associated with the swim time trait are involved in 226 
hypoxic events characteristic of swimming [51]. It is possible that the rs6949152 G allele within the NRF1 gene 227 
results in lower activity of NRF transcription factor and therefore increased levels of Hypoxia Inducible Factor 1 228 
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alpha (HIF1α). This would cause reduced oxidative metabolic processing and therefore lead to the increase in 229 
swim time that is associated with the variant (β = 0.2459 hours). Additionally, the CKMM protein has been shown 230 
to exhibit protective effects during mild hypoxia and therefore e hypothesised that the rs8111989 variant would 231 
increase the functionality of the CKMM protein, resulting in protection against re-oxygenation induce muscle 232 
damage and decreased swim time [52].  233 
Although multiple SNPs examined in this study passed our nominal threshold for significance, which was 234 
unexpected given our relatively small sample sizes, all variants nominally significant in each cohort have 235 
previously been investigated as causative variants in multiple exercise studies.  236 
Using a MassARRAY design of 36 SNPs, we found a significant association for the rs1474347 SNP in IL6 with 237 
the change in VO2max trait in a cohort of moderately trained individuals. Furthermore, 16 other SNPs were shown 238 
to have nominal association with exercise response in the Gene SMART cohort, or Ironman performance in 239 
highly-trained athletes. As such, these markers may be useful in the development of tailored genetic panel 240 
screening and therapeutics in sports science and exercise intolerant disorders. However, to more fully exploit their 241 
applicability in this context, confirmation of the genotypic phenotype on gene function is required. Whilst this is 242 
outside the purview of this study, we have successfully replicated the significance of several exercise genes in 243 
two relatively small exercise study cohorts through nominally significant associations identified in the study 244 
cohorts. We were also able to implicate and ascertain directionality of SNPs between the different phenotypic 245 
traits. Additionally, the different variants associated with each cohort highlight the need to examine multiple 246 
cohorts of differing fitness levels and training capabilities. However, more replication studies are required in 247 
conjunction with functional transcriptomic/proteomic studies to confirm the genes and pathways associated with 248 
exercise adaptations. The use of multi-centre studies and consortia, such as the Athlome study consortium would 249 
be helpful to better facilitate these efforts to further develop the field of exercise genomics research [53]. 250 
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